Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects

DNA vaccines containing only antigenic components have limited efficacy and may fail to induce effective immune responses. Consequently, adjuvant molecules are often added to enhance immunogenicity. In this study, we generated a tumor vaccine using a plasmid encoding NMM (NY-ESO-1/MAGE-A3/MUC1) targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Song, Weiwei, Xu, Qiang, Liu, Yachao, Liu, Hezhong, Guo, Runzi, Chiou, Chuang-Jiun, Gao, Kun, Jin, Baofeng, Chen, Changfeng, Li, Zhongming, Yan, Jinqi, Yu, Jiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142307/
https://www.ncbi.nlm.nih.gov/pubmed/37128699
http://dx.doi.org/10.1080/21645515.2023.2202127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142307/
https://www.ncbi.nlm.nih.gov/pubmed/37128699
http://dx.doi.org/10.1080/21645515.2023.2202127

Ejemplares similares